Monoclonal Anti-Gamma Interferon Antibodies Enhance Experimental Allergic Encephalomyelitis

References

• Bernard CC, Carnegie PR. Experimental allergic encephalomyelitis:immunologic response to mouse spinal cord and myelin basic proteins. Journal of Immunology 1975; 114: 1537–1540
   PubMed Web of Science ®Google Scholar
• Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1 + 2 -T lymphocytes. J Immunol 1981; 127: 1420–1423
   PubMed Web of Science ®Google Scholar
• Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 1989; 124: 132–143
   PubMed Web of Science ®Google Scholar
• Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA 1992; 89: 574–578
   PubMed Web of Science ®Google Scholar
• Jacobs CA, Baker PE, Roux ER. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J. Immunol 1991; 146: 2983–2989
   PubMedGoogle Scholar
• Selmaj K, Raine CS, Cross AH. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991; 30: 694–700
   PubMed Web of Science ®Google Scholar
• Racke MK, Dhib Jalbut S., Cannella B, Albert PS, Raine CS, McFarlin DE. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol 1991; 146: 3012–3017
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Perussia B. Immune interferon:a pleiotropic lymphokine with multiple effects. Immunology Today 1985; 6: 131–136
   PubMedGoogle Scholar
• Noma T, Dorf ME. Modulation of suppressor T cell induction with gamma interferon. Journal of Immunology 1985; 135: 3655–3660
   Google Scholar
• Elmasry MN, Fox EJ, Rich RR. Sequential effects of prostaglandins and interferon-gamma on differentiation of CD8 + suppressor cells. Journal of Immunology 1987; 135: 688–694
   Google Scholar
• Whal LM, Corcoran ME, Mergenhagen SE, Finbloom DS. Inhibition of phospholipase activity in human monocytes by IFN-gamma blocks endogenous prostaglandin E2-dependent collagenase production. Journal of Immunology 1990; 144: 3518–3522
   Google Scholar
• Veys EM, Mielants H, Verbruggen G, Grosclaude JP, Schindler JD. Interferon gamma in rheumatoid arthritis: a double blind study comparing human recombinant interferon gamma with placebo. Journal of Rheumatology 1988; 15: 570
   PubMedGoogle Scholar
• Nakajima H, Takamori H, Hiyama Y, Tsukada W. The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin Exp Immunol 1990; 81: 441–445
   PubMedGoogle Scholar
• Mauritz NJ, Holmdahl R, Jonsson R, van der Meide PH, Scheynius A, Klareskog L. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis & Rheumatism 1988; 31: 1297–1304
   PubMed Web of Science ®Google Scholar
• Jacob CO, Holoshitz J, van der Meide P, Strober S, McDevitt HO. Heterogeneous effects of IFN-gamma in adjuvant arthritis. J. Immunol 1989; 142: 1500–1505
   PubMedGoogle Scholar
• Wiesenberg I, van der Meide PH, Schellekens H, Alkan SS. Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin Exp Immunol 1989; 78: 245–249
   PubMed Web of Science ®Google Scholar
• Jacob CO, van der Meide PH, McDevitt HO. In vivo treatment of (NZB × NZW)Fl lupus-like nephritis with monoclonal antibody to gamma interferon. J. Exp Med 1987; 166: 798–803
   PubMed Web of Science ®Google Scholar
• Panitch HS, Hirsch RL, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987; 37: 1097–1102
   PubMed Web of Science ®Google Scholar
• Billiau A, Heremans H, Vandekerckhove F. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 1988; 140: 1506–1510
   PubMed Web of Science ®Google Scholar
• Voorthuis JA, Uitdehaag BM, De Grott CJ, Goede PH, van der Meide PH, Dijkstra CD. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin Exp Immunol 1990; 81: 183–188
   PubMed Web of Science ®Google Scholar
• Duong TT, St Louis J., Gilbert JJ, Finkelman FD, Strejan GH. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treament on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 1992; 36: 105–115
   PubMed Web of Science ®Google Scholar
• Twardzik DR, Mikovits JV, Ranchalis JE, Purchio AF, Ellingsworth L, Ruscetti FW. Gamma-interferon-induced activation of latent transforming growth factor-beta by human monocytes. Annals of the New York Academy of Sciences 1990; 593: 276–284
   PubMed Web of Science ®Google Scholar
• Antel JP, Bania MB, Reder A, Cashman N. Activated suppressor cell dysfunction in progressive multiple sclerosis. Journal of Immunology 1986; 137: 141
   Google Scholar
• Fierz W, Endler B, Reske K, Wekerle H, Fontana A. Astrocytes as antigen-presenting cells. I. Induction of la antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol 1985; 134: 3785–3793
   PubMed Web of Science ®Google Scholar
• McCarron RM, Spatz M, Kempski O, Hogan RN, Muehl L, McFarlin DE. Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J Immunol 1986; 137: 3428–3435
   PubMed Web of Science ®Google Scholar
• Suzumura A, Mezitis SG, Gonatas NK, Silberberg DH. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of la antigen expression by gamma-interferon. J Neuroimmunol 1987; 15: 263–278
   PubMed Web of Science ®Google Scholar
• Mustafa MI, Diener P, Hojeberg B, van der Meide P, Olsson T. T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1991; 31: 165–177
   PubMed Web of Science ®Google Scholar
• Karpus WJ, Swanborg RH. CD4 suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental allergic encephalomyelitis. Journal of Immunology 1989; 143: 3492–3497
   PubMed Web of Science ®Google Scholar
• Kalman B, Knobler RL, Perreault M. Inhibition of EAE by intracerebral injection of interferon-gamma (IFN-gamma). Neurology 1992; 42
   Google Scholar
• Skoglund C, Scheynius A, Holmdahl R, van der Meide PH. Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against gamma interferon. Clin Exp Immunol 1988; 71: 428–432
   PubMedGoogle Scholar
• Johns LD, Flanders KC, Ranges GE, Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J Immunol 1991; 147: 1792–1796
   PubMed Web of Science ®Google Scholar
• Karpus WJ, Swanborg RH. CD4 + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J Immunol 1991; 146: 1163–1168
   PubMed Web of Science ®Google Scholar
• Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palla-Dino MA, Thorbecke GJ. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 1991; 88: 2918–2921
   PubMed Web of Science ®Google Scholar
• Fiorentino DF, Zlotnik A, Vieira P. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Thl cells. J Immunol 1991; 146: 3444–3451
   PubMed Web of Science ®Google Scholar
• Powrie F, Mason D. OX-22high CD4 + T cells induce wasting disease with multiple organ pathology: prevention by the OX-221ow subset. J Exp Med 1990; 172: 1701–1708
   PubMed Web of Science ®Google Scholar
• Whal SM, Allen JB, Ohura K, Chenoweth DE, Hand AR. IFN-gamma inhibits inflammatory cell recruitment and the evolution of bacterial cell wall-induced arthritis. J Immunol 1991; 146: 95–100
   Google Scholar
• Sobel RA, Hafler DA, Castro EE, Morimoto C, Weiner HL. The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. Journal of Immunology 1988; 140: 2210–2214
   PubMed Web of Science ®Google Scholar
• Bever CT., Panitch HS., Levy HB, McFarlin DE, Johnson KP. Gamma-interferon induction in patients with chronic progressive MS. Neurology 1991; 41: 1124–1127
   Google Scholar